Abnormal Psychology An Integrative Approach 8th Edition Barlow Durand Test Bank

Abnormal Psychology An Integrative Approach 8th Edition Barlow Durand Test Bank Built from the public Stuvia preview and broad chapter structure, then expanded into an original learning resource. It does not reproduce the 909-page paid test bank. Core coverage: psychopathology foundations • assessment & diagnosis • research • anxiety/OCD/trauma • somatic & dissociative disorders • mood disorders & suicide • eating/sleep • health psychology • sexual/paraphilic disorders & gender dysphoria • substance/addictive disorders • personality disorders • schizophrenia/psychosis • neurodevelopmental disorders • neurocognitive disorders • legal/ethical mental-health services Abnormal Psychology 8th Ed — Original Enhanced Study Guide Page1. SOURCE REVIEW & STUDY STRATEGY The linked Stuvia listing is a 909-page test bank, uploaded January 16, 2022, written for 2021/2022, and presented as questions and answers. Its public preview begins with foundational concepts such as the four Ds of abnormality, historical explanations including demonology, and early contributors such as Hippocrates. ■cite■turn0search0■ More recent Stuvia listings preserve the same broad 16-chapter architecture: historical context; integrative psychopathology; assessment/diagnosis; research methods; anxiety/trauma/OCD-related disorders; somatic/dissociative disorders; mood disorders/suicide; eating/sleep; health psychology; sexual/paraphilic/gender dysphoria; substance/addictive/impulse-control disorders; personality disorders; schizophrenia/psychotic disorders; neurodevelopmental disorders; neurocognitive disorders; and mental-health services/legal/ethical issues. ■cite■turn0search1■turn0search5■ Best exam strategy: learn disorders by their defining pattern, duration/course, functional impact, differential diagnosis, and treatment logic—not by memorizing isolated labels. The integrative mindset• Social/cultural: relationships, systems, culture, inequality and environmental stressors. • Integrative: combines interacting mechanisms and avoids false either/or explanations. 4. ASSESSMENT, DIAGNOSIS & CLINICAL FORMULATION Clinical interview essentials • Chief concern and patient's own explanation of the problem. • Onset, duration, frequency, severity, triggers, maintaining factors and functional consequences. • Past psychiatric history, medical history, medications, substances, trauma and developmental history. • Family psychiatric/medical history and relevant social/cultural context. • Mental status examination: appearance, behavior, speech, mood/affect, thought process/content, perception, cognition, insight and judgment. • Risk assessment: suicidal thoughts/intent/plan, homicidal risk, psychosis, access to lethal means, protective factors and immediate safety needs. Diagnosis vs formulation Diagnosis organizes symptoms into a recognized syndrome using explicit criteria. Formulation explains why this patient may be experiencing symptoms now, including vulnerabilities, precipitants, perpetuating factors and protective factors. Differential diagnosis checklist • Is there a medical or neurologic condition that could mimic the syndrome? • Could a medication or substance cause the symptoms? • Could another psychiatric disorder better explain the pattern? • Are symptoms episodic, chronic, situational, or triggered? • Is there psychosis, mania, delirium, intoxication or withdrawal? • Does developmental stage alter what is expected? 5. RESEARCH METHODS & EVIDENCE • Descriptive studies characterize who, what, when and where. • Correlational studies identify associations but do not establish causation. • Experiments/randomized trials provide stronger evidence for causalPanic disorder Agoraphobia Specific phobia Social anxiety disorder OCD PTSD Treatment principles • Psychotherapy is first-line or highly important for many anxiety/OCD/trauma conditions. • CBT targets avoidance, catastrophic interpretations and maladaptive learning. • Exposure-based approaches deliberately reduce avoidance while building new learning. • SSRIs/SNRIs are common evidence-based pharmacologic options for several anxiety-spectrum disorders. • Benzodiazepines can reduce acute anxiety but carry sedation, dependence, misuse and withdrawal concerns; they are not a universal long-term solution. • Treatment should be matched to diagnosis, severity, comorbidity, patient preference and safety. 7. SOMATIC SYMPTOM & DISSOCIATIVE DISORDERS • Somatic symptom disorder centers on distressing somatic symptoms plus excessive thoughts, feelings or behaviors related to them; symptoms are not dismissed as 'imaginary.' • Illness anxiety disorder centers on preoccupation with having/acquiring serious illness with relatively limited somatic symptoms. • Conversion disorder (functional neurological symptom disorder) involves neurological-type symptoms inconsistent with recognized neurological disease patterns, diagnosed positively through clinical features rather than simply 'normal tests.' • Dissociative disorders involve disruption/integration of consciousness, memory, identity, perception or sense of self/environment. • Rule out medical/neurologic explanations and substance/medication effects appropriately. Exam trap: avoid stigmatizing language. Symptoms can be real and disabling even when no structural disease is identified. 8. MOOD DISORDERS & SUICIDE Major depressive episode Abnormal Psychology 8th Ed — Original Enhanced Study Guide Page• Core symptoms include depressed mood and/or loss of interest/pleasure plus associated cognitive, behavioral and physical symptoms. • Assess duration, severity, impairment, psychotic features, anxious distress, substance/medical causes and bipolar history. • Sleep/appetite changes can occur in either direction; psychomotor changes may be observable. • Alwsignificant distress/impairment or acting on urges involving nonconsenting individuals or other relevant harm criteria. • Gender dysphoria focuses on clinically significant distress/impairment associated with incongruence, not identity itself. • Use respectful, patient-centered language and avoid pathologizing identity or consensual adult behavior. 12. SUBSTANCE-RELATED, ADDICTIVE & IMPULSE-CONTROL DISORDERS Substance-use disorder framework • Assess impaired control, social impairment, risky use and pharmacologic features such as tolerance/withdrawal. • Severity is based on the number of criteria met, not simply amount used. • Screen for co-occurring psychiatric disorders and medical complications. • Motivational interviewing can strengthen readiness and reduce confrontation. • Evidence-based treatment may include psychotherapy, mutual-support approaches, medications, harm-reduction strategies and higher levels of care when needed. Current context: SAMHSA's 2025 NSDUH estimates that 44.6 million people age 12+ had a substance use disorder in the past year, while only 11.0% of those with an SUD received substance-use treatment. The same report estimates 21.6% of adults received some mental-health treatment in 2025. ■cite■turn1search0■ Withdrawal vs intoxication • Identify the substance, timing of last use, pattern of use, expected withdrawal syndrome and medical risk. • Some withdrawal states can be life-threatening and require monitored medical management. • Do not assume all intoxication presents as sedation; stimulants, hallucinogens and mixed substances can produce agitation, psychosis or autonomic instability. 13. PERSONALITY DISORDERS Personality disorders describe enduring patterns of inner experience and behavior that deviate from cultural expectations, are pervasive/inflexible, begin by adolescence or early adulthood, are stable over time, and cause impairment or distress. Cluster A B C Traditional teaching shorthand Odd/eccentric: paranoid, schizoid, schizotypal. Dramatic/emotional/erratic: antisocial, borderline, histrionic, narcissistic. Anxious/fearful: avoidant, dependent, obsessive-compulsive personality disorder. Abnormal Psychology 8th Ed — Original Enhanced Study Guide Page 6